the American Heart Association (AHA) of a
retrospective analysis which found that
initiation of insulin glargine in patients
with type 2 diabetes was associated with a
lower incidence rate of myocardial
infarction as compared with NPH Insulin
November 7, 2007 Announcement of the start of phase II
testing of sanofi pasteur's cell culture-
based seasonal influenza vaccine
November 6, 2007 Presentation by sanofi pasteur to the
American Society of Tropical Medicine and
Hygiene (ASTMH) of positive results in the
development of a vaccine for the worldwide
prevention of dengue fever
November 10, 2007 Presentation at the Congress of the American
College of Allergy, Asthma & Immunology
(ACAAI) of new data giving further
information on the safety and efficacy of
Nasacort(R) AQ in children aged 2-5 years
old with year-round allergic rhinitis
November 13, 2007 Announcement of the signature of an
exclusive global collaboration agreement
between sanofi pasteur and Acambis plc for
the development and marketing of a West Nile
virus vaccine
November 13, 2007 Announcement that the European Commission
had endorsed the positive opinion of the
EMEA on Acomplia(R), to include the results
'/>"/>
| SOURCE sanofi-aventis Copyright©2008 PR Newswire. All rights reserved |